224 related articles for article (PubMed ID: 27276215)
1. Honokiol targets mitochondria to halt cancer progression and metastasis.
Pan J; Lee Y; Wang Y; You M
Mol Nutr Food Res; 2016 Jun; 60(6):1383-95. PubMed ID: 27276215
[TBL] [Abstract][Full Text] [Related]
2. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Pan J; Lee Y; Zhang Q; Xiong D; Wan TC; Wang Y; You M
Cancer Prev Res (Phila); 2017 Feb; 10(2):133-141. PubMed ID: 27849557
[TBL] [Abstract][Full Text] [Related]
3. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
[TBL] [Abstract][Full Text] [Related]
5. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
Kaushik G; Kwatra D; Subramaniam D; Jensen RA; Anant S; Mammen JM
Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
[TBL] [Abstract][Full Text] [Related]
6. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
[TBL] [Abstract][Full Text] [Related]
7. Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.
Prasad R; Katiyar SK
Adv Exp Med Biol; 2016; 928():245-265. PubMed ID: 27671820
[TBL] [Abstract][Full Text] [Related]
8. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Oct; 6(30):29947-62. PubMed ID: 26359358
[TBL] [Abstract][Full Text] [Related]
9. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
[TBL] [Abstract][Full Text] [Related]
10. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
11. [Research progress in anticancer effects and molecular targets of honokiol in experimental therapy].
Chen SZ
Yao Xue Xue Bao; 2016 Feb; 51(2):202-7. PubMed ID: 29856535
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87.
Zhang Y; Ren X; Shi M; Jiang Z; Wang H; Su Q; Liu Q; Li G; Jiang G
Oncol Rep; 2014 Nov; 32(5):2038-46. PubMed ID: 25175884
[TBL] [Abstract][Full Text] [Related]
13. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract][Full Text] [Related]
14. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
Wang WD; Shang Y; Li Y; Chen SZ
Acta Pharmacol Sin; 2019 Sep; 40(9):1219-1227. PubMed ID: 31235819
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells.
Chou HC; Lu CH; Su YC; Lin LH; Yu HI; Chuang HH; Tsai YT; Liao EC; Wei YS; Yang YT; Chien YA; Yu XR; Lee YR; Chan HL
Life Sci; 2018 Aug; 207():184-204. PubMed ID: 29883720
[TBL] [Abstract][Full Text] [Related]
17. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
18. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
Zhou B; Li H; Xing C; Ye H; Feng J; Wu J; Lu Z; Fang J; Gao S
Biochem Pharmacol; 2017 Mar; 128():12-25. PubMed ID: 28043811
[TBL] [Abstract][Full Text] [Related]
19. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
Kumar A; Kumar Singh U; Chaudhary A
Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
[TBL] [Abstract][Full Text] [Related]
20. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Singh T; Katiyar SK
Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
